Antimicrobial Device Coatings Platform
Prevention of device-related infections (e.g., catheters, implants)
Key Facts
About Allvivo Vascular
Allvivo Vascular is a private, pre-revenue medical device company developing a novel antimicrobial technology platform centered on engineered peptides (ASP-1, ASP-2) and biocompatible formulations. The platform is designed to coat medical devices and treat wounds, offering broad-spectrum protection, biofilm eradication, and activity against multidrug-resistant bacteria with high biocompatibility. The company operates through collaborations with licensees and marketing partners, positioning its technology as a potential alternative to traditional antimicrobials like silver. Founded in 2003, Allvivo appears to be in a late-stage development or partnership-driven commercialization phase for its platform technologies.
View full company profile